⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANTX News
AN2 Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
ANTX
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV)
businesswire.com
ANTX
AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference
businesswire.com
ANTX
Biotechnology Instruments Market Projected to Reach US$ 141.70 Billion by 2035 | Astute Analytica
globenewswire.com
ILMN
TMO
BRKR
LLY
ONON
PACB
RGEN
QGEN
AMGN
BMY
GILD
NVO
ANTX
DTIL
AGNC
DHR
Shinkai Joins the Linux Foundation's Agentic AI Foundation as a Launch Member to Advance Open Standards for Agentic AI
prnewswire.com
AMZN
ANTX
BB
GOOG
MSFT
OPRA
Cell Therapy Technologies Market worth $7.91 billion by 2030 | MarketsandMarkets™
prnewswire.com
DHR
TMO
AVTR
BIIB
BDX
GLW
ANTX
AN2 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business and Scientific Highlights
businesswire.com
ANTX
AN2 Therapeutics Announces Research Collaboration With GSK to Advance Boron-Based LeuRS-Inhibitors Targeting Tuberculosis (TB)
businesswire.com
ANTX
AN2 Therapeutics to Participate in Fireside Chat at Evercore HealthCONx Conference
businesswire.com
ANTX